Correlation Between Commonwealth Bank and Spyre Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Commonwealth Bank and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Commonwealth Bank and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Commonwealth Bank of and Spyre Therapeutics, you can compare the effects of market volatilities on Commonwealth Bank and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Commonwealth Bank with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Commonwealth Bank and Spyre Therapeutics.

Diversification Opportunities for Commonwealth Bank and Spyre Therapeutics

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Commonwealth and Spyre is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Commonwealth Bank of and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Commonwealth Bank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Commonwealth Bank of are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Commonwealth Bank i.e., Commonwealth Bank and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between Commonwealth Bank and Spyre Therapeutics

Assuming the 90 days horizon Commonwealth Bank of is expected to generate 0.36 times more return on investment than Spyre Therapeutics. However, Commonwealth Bank of is 2.77 times less risky than Spyre Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about 0.01 per unit of risk. If you would invest  9,614  in Commonwealth Bank of on September 5, 2024 and sell it today you would earn a total of  700.00  from holding Commonwealth Bank of or generate 7.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.44%
ValuesDaily Returns

Commonwealth Bank of  vs.  Spyre Therapeutics

 Performance 
       Timeline  
Commonwealth Bank 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Commonwealth Bank of are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Commonwealth Bank may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Spyre Therapeutics is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Commonwealth Bank and Spyre Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Commonwealth Bank and Spyre Therapeutics

The main advantage of trading using opposite Commonwealth Bank and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Commonwealth Bank position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.
The idea behind Commonwealth Bank of and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
CEOs Directory
Screen CEOs from public companies around the world